Cathepsin D as a Prognostic Marker in Endometrial Cancer
Author Information
Author(s): A Losch, P Kohlberger, G Gitsch, A Kaider, G Breitenecker, Ch Kainz
Primary Institution: University of Vienna
Hypothesis
The study investigates the prognostic value of cathepsin D expression in endometrial adenocarcinoma.
Conclusion
Cathepsin D expression is a significant prognostic marker for overall survival in patients with endometrial adenocarcinoma.
Supporting Evidence
- 35 out of 115 cases showed positive cathepsin D expression.
- Cathepsin D expression was found to have significant prognostic value for overall survival.
- In multivariate analysis, cathepsin D had an independent prognostic value with a relative risk of 3.8.
Takeaway
This study found that a protein called cathepsin D can help doctors predict how well patients with a certain type of cancer will do after treatment.
Methodology
Immunohistochemistry was used to detect cathepsin D in tissue specimens from patients with endometrial adenocarcinoma.
Limitations
Lymph node staging was not performed routinely, limiting the analysis of its correlation with cathepsin D expression.
Participant Demographics
Mean age of participants was 64.3 years, with a range from 36 to 85 years; seven patients were premenopausal.
Statistical Information
P-Value
0.002
Confidence Interval
1.4 - 10.0
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website